Acute Dental Pain Management Guideline (2022)
We want to hear from you!
To submit comments, please use the form below. Comments may be general or specific. If offering specific feedback, please note the exact part of the guideline's recommendations and good practice statements that you are referring to and provide any references to support your comments.
All submitted feedback will be reviewed by the guideline's authors. The deadline to submit comments is December 5.
Frequently asked questions
The clinical practice guideline on the management of acute dental pain is being written by an expert panel and a team of methodologists at the ADA Science & Research Institute, University of Pittsburgh, and the University of Pennsylvania.
This project is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $1.5 million with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.
The upcoming guideline for the management of acute dental pain (surgical and non-surgical) was informed by a systematic review of the best available scientific evidence. An expert panel chaired by Paul Moore, DMD, PhD, a professor of pharmacology at the University of Pittsburgh School of Dental Medicine, then used this review to draft the recommendations and good practice statements presented here.